Shu-Hai Chen, Bing-Yuan Zhang, Bin Zhou, Cheng-Zhan Zhu, Le-Qi Sun, Yu-Jie Feng: Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche. Am J Cancer Res 2019;9(1):1-21. (Full text, PDF)
Zheng-Qian Bian, Yang Luo, Feng Guo, Yi-Zhou Huang, Ming Zhong, Hui Cao: Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway. Am J Cancer Res 2019;9(1):22-35. (Full text, PDF)
Jia Ren, Mengjie Yang, Fengyang Xu, Juwu Chen: microRNA-758 inhibits the malignant phenotype of osteosarcoma cells by directly targeting HMGA1 and deactivating the Wnt/β-catenin pathway. Am J Cancer Res 2019;9(1):36-52. (Full text, PDF)
Emily B Ehlerding, Hye Jin Lee, Dawei Jiang, Carolina A Ferreira, Christopher D Zahm, Peng Huang, Jonathan W Engle, Douglas G McNeel, Weibo Cai: Antibody and fragment-based PET imaging of CTLA-4+ T-cells in humanized mouse models. Am J Cancer Res 2019;9(1):53-63. (Full text, PDF)
Fengtao You, Yinyan Wang, Licui Jiang, Xuejun Zhu, Dan Chen, Lei Yuan, Gangli An, Huimin Meng, Lin Yang: A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia. Am J Cancer Res 2019;9(1):64-78. (Full text, PDF)
Boya Zhong, Masato Shingyoji, Michiko Hanazono, Thảo Thi Thanh Nguyễn, Takao Morinaga, Yuji Tada, Kenzo Hiroshima, Hideaki Shimada, Masatoshi Tagawa: A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway. Am J Cancer Res 2019;9(1):79-93. (Full text, PDF)
Ki Sa Sung, Sun-Jick Kim, Sang Woo Cho, Ye-Jin Park, Kun Tae, Cheol Yong Choi: Functional impairment of the HIPK2 small ubiquitin-like modifier (SUMO)-interacting motif in acute myeloid leukemia. Am J Cancer Res 2019;9(1):94-107. (Full text, PDF)
Fei Chen, Yuhong Li, Meijun Li, Liang Wang: Long noncoding RNA GAS5 inhibits metastasis by targeting miR-182/ANGPTL1 in hepatocellular carcinoma. Am J Cancer Res 2019;9(1):108-121. (Full text, PDF)
Maiya J Mao, Donna E Leonardi: Vascular-endothelial response to IDH1 mutant fibrosarcoma secretome and metabolite: implications on cancer microenvironment. Am J Cancer Res 2019;9(1):122-133. (Full text, PDF)
Min Hu, Wenzheng Guo, Yueling Liao, Dongliang Xu, Beibei Sun, Hongyong Song, Tong Wang, Yanbin Kuang, Bo Jing, Kaimi Li, Jing Ling, Feng Yao, Jiong Deng: Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features. Am J Cancer Res 2019;9(1):134-144. (Full text, PDF)
Bowen Sun, Nathaniel R Jensen, Dongjun Chung, Meixiang Yang, Amanda C LaRue, Hiu Wing Cheung, Qi Wang: Synergistic effects of SHP2 and PI3K pathway inhibitors in GAB2-overexpressing ovarian cancer. Am J Cancer Res 2019;9(1):145-159. (Full text, PDF)
Isabelle Matte, Perrine Garde-Granger, Paul Bessette, Alain Piché: Serum CA125 and ascites leptin level ratio predicts baseline clinical resistance to first-line platinum-based treatment and poor prognosis in patients with high grade serous ovarian cancer. Am J Cancer Res 2019;9(1):160-170. (Full text, PDF)
Chen Gan, Yue Lv, Jingjing Zhao, Herta H Chao, Chiang-Shan R Li, Congjun Zhang, Fengqiong Yu, Huaidong Cheng: Neural correlates of chemotherapy-induced emotion regulation impairment in breast cancer patients. Am J Cancer Res 2019;9(1):171-179. (Full text, PDF)
Wei-Jan Wang, Jung-Mao Hsu, Ying-Nai Wang, Heng-Huan Lee, Hirohito Yamaguchi, Hsin-Wei Liao, Mien-Chie Hung: An essential role of PRMT1-mediated EGFR methylation in EGFR activation by ribonuclease 5. Am J Cancer Res 2019;9(1):180-185. (Full text, PDF)
Can-Can Zheng, Hui-Fang Hu, Pan Hong, Qi-Hua Zhang, Wen Wen Xu, Qing-Yu He, Bin Li: Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer. Am J Cancer Res 2019;9(1):186-197. (Full text, PDF)
